AAAAAA

   
Results: 1-9 |
Results: 9
Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma
Authors: Solorzano, CC Baker, CH Tsan, R Traxler, P Cohen, P Buchdunger, E Killion, JJ Fidler, IJ
Citation: Cc. Solorzano et al., Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma, CLIN CANC R, 7(8), 2001, pp. 2563-2572
Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002
Authors: Shinohara, H Bucana, CD Killion, JJ Fidler, IJ
Citation: H. Shinohara et al., Intensified regression of colon cancer liver metastases in mice treated with irinotecan and the immunomodulator JBT 3002, J IMMUNOTH, 23(3), 2000, pp. 321-331
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation
Authors: Yano, S Herbst, RS Shinohara, H Knighton, B Bucana, CD Killion, JJ Wood, J Fidler, IJ
Citation: S. Yano et al., Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation, CLIN CANC R, 6(3), 2000, pp. 957-965
Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growthfactor receptor tyrosine kinases
Authors: Xu, L Yoneda, J Herrera, C Wood, J Killion, JJ Fidler, IJ
Citation: L. Xu et al., Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growthfactor receptor tyrosine kinases, INT J ONCOL, 16(3), 2000, pp. 445-454
Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002
Authors: Kumar, R Xie, KP Eue, I Dong, ZY Killion, JJ Fidler, IJ
Citation: R. Kumar et al., Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002, INT J IMMUN, 22(6), 2000, pp. 431-443
Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
Authors: Bruns, CJ Shinohara, H Harbison, MT Davis, DW Nelkin, G Killion, JJ McConkey, DJ Dong, ZY Fidler, IJ
Citation: Cj. Bruns et al., Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages, CANCER RES, 60(1), 2000, pp. 2-7
Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytes
Authors: Yoneda, J Killion, JJ Bucana, CD Fidler, IJ
Citation: J. Yoneda et al., Angiogenesis and growth of murine colon carcinoma are dependent on infiltrating leukocytes, CANC BIO R, 14(3), 1999, pp. 221-230
Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium
Authors: Shinohara, H Killion, JJ Bucana, CD Yano, S Fidler, IJ
Citation: H. Shinohara et al., Oral administration of the immunomodulator JBT-3002 induces endogenous interleukin 15 in intestinal macrophages for protection against irinotecan-mediated destruction of intestinal epithelium, CLIN CANC R, 5(8), 1999, pp. 2148-2156
Orthotopic models are necessary to predict therapy of transplantable tumors in mice
Authors: Killion, JJ Radinsky, R Fidler, IJ
Citation: Jj. Killion et al., Orthotopic models are necessary to predict therapy of transplantable tumors in mice, CANC METAST, 17(3), 1998, pp. 279-284
Risultati: 1-9 |